Keywords
miniscrews - infrazygomatic crest area - TADs - orthodontics - mini-implant
Introduction
Orthodontic treatment mainly depends on two mechanics: facilitating the desired teeth
movement to the new position and preventing unwanted teeth movement, which requires
anchorage control. Anchorage enhancement has progressed greatly over the past century,
and one of these milestones was the development of mini-implants placed intraradicularly.
Recently introduced extraradicular mini-implants, including temporary anchorage devices
(TADs), are inserted into the infrazygomatic crest (IZC) area in the upper arch and
buccal shelf (BS) in the lower arch.[1] Intraradicular and extraradicular mini-implants have accompanied a renaissance in
orthodontics over the last decade, introducing the concept of absolute or maximum
anchorage, in addition to anchorage recently used to accelerate tooth movement.[2] These advancements serve as additional tools for orthodontists, enabling them to
address new clinical challenges and transform borderline surgical cases into nonsurgical
ones without compromising the achieved results.[3]
Intraradicular TADs have many limitations, such as root proximity, which carries the
risk of root damage, a major risk factor for TAD failure.[4] Their placement between roots may also restrict the full arch movement as it interferes
with mesiodistal root movements.[5] To reduce eventual failures due to proximity to the roots and enable orthodontic
mechanics to obtain adequate tooth movements, orthodontists have attempted to insert
TADs into extra-alveolar regions such as the IZC and BS.[6] Studies have shown that from a clinical perspective, the IZC TAD position remains
stable and could be efficiently used for anchorage to improve orthodontic tooth movement.[7]
Furthermore, inserting TADs into the IZC has many advantages, such as thicker bone,
which allows the insertion of longer mini-implants, greater bone contact, and better
primary stability.[8] In addition, the two cortical plates (the buccal cortical plate and the sinus floor)
have greater bone density (an anatomic advantage), which may provide better primary
stability for the mini-implant due to bicortical fixation. Moreover, TADs inserted
into the IZC have another advantage over intraradicular mini-implants: they allow
full arch distalization without root contact issues.[9]
Maxillary sinus perforation is considered a major issue when using TADs inserted into
the IZC.[10] However, Chang et al reported that it does not affect the 6-month postinsertion
survival rate, and thus, the failure rate of TADs inserted into the IZC.[10] Nonetheless, sinus penetration is still regarded as a vital structure damage. Moreover,
evidence suggests that involving the sinus to enhance primary stability is unnecessary,
where larger TADs compromise bone integrity over a greater area than smaller TADs;
therefore, larger TADs should be avoided when possible.
Additionally, the optimal combination of mini-implant size and insertion angle is
critical for achieving good primary stability, reducing the risk of sinus penetration,
and having high clinical performance.[11] While failure rates may appear no better with longer mini-implants than with shorter
mini-implants, they do have disadvantages regarding potential side effects. A longer
implant has a higher likelihood of damaging adjacent structures.[12] Therefore, this study examined how the length of the TAD inserted into the IZC affects
sinus penetration, stability, and failure rate, which have been insufficiently explored
in the previous studies.[10] It compares the two longest available IZC mini-implants (12 and 14 mm) used in the
IZC area.[13]
Aim of the Study
This study aimed to examine how the length of the TADs inserted into the IZC affects
sinus penetration, stability, and failure rate.
Objectives
Primary Objective
The primary objective was to evaluate the influence of mini-implant length on its
early stability, long-term stability, and failure rate in the IZC area.
Secondary Objectives
The secondary objective was to assess how mini-implant length affects sinus penetration
and patients' pain perception 1 week postinsertion.
Materials and Methods
Study Design
This study was a single-operator, split-mouth, double-blind, randomized clinical trial
with a 1:1 allocation ratio and per protocol analysis.
Subjects/Settings
Forty-eight patients received TADs inserted bilaterally into the IZC. This study was
ethically approved by the ethics committee of the College of Dentistry, University
of Baghdad[a] before it commenced (project no. 784423) and registered at ClinicalTrials.gov (ID:
NCT06293872). Patients who met the inclusion criteria were asked to assign a comprehensive
consent form before the start of the study.
Procedure/Intervention
Sample Selection
Consecutive patients were eligible to participate in this study if they met the following
inclusion criteria: (1) aged 18 to 30 years, (2) patients currently receiving orthodontic
treatment with the use of a fixed orthodontic appliance and need mini-implant placement
into the upper buccal posterior area (IZC), (3) patients who have the desire and ability
to comply with the trial protocol, and (4) recommended for the use of bilateral miniscrews.
The exclusion criteria were as follows: (1) clinical examination suggesting sinus
inflammation or a history of chronic sinusitis or sinus surgery pathology before mini-implant
insertion, and (2) syndromic disease, facial trauma, and/or a history of surgery for
bone disease. The dropout criteria were as follows: (1) postinsertion cone beam computed
tomography (CBCT) showed that the TAD was inserted interradicular rather than into
the IZC area, and (2) the patient decided to withdraw from the study.
Randomization
According to a randomized split-mouth design ([Fig. 1]), each patient received a 12-mm mini-implant on one side and a 14-mm mini-implant
on the other side.[13] The mini-implant pairs were coded for the right and left sides and arranged in an
alternating form to guarantee that an equal number of each length was inserted into
the right and left sides.[14]
Fig. 1 Flowchart illustrates the workflow of the randomized clinical trial.
Surgical Procedure
Before mini-implant insertion, the patients were instructed to rinse their mouths
with chlorhexidine mouthwash, and then local anesthesia was applied. The mesiodistal
site for mini-implant insertion located between the first and second molars is the
most frequently recommended insertion site for TADs in the IZC. The mini-implants
were placed by a postgraduate student (A.A.) under the supervision of an experienced
clinician following a well-established clinical protocol. While the clinical recommendation
for the vertical distance of mini-implant insertion into the IZC area is 14 to 16 mm
measured from the occlusal plane of the maxillary first molar,[9] using the vertical axis of the upper first permanent molar could be a safe method
for IZC TADs insertion[15] ([Fig. 2]), also it is important to note that the optimal height for insertion is higher for
male than female.[16]
Fig. 2 Insertion site of mini-implant. (A) Vertical distance for infrazygomatic crest (IZC) temporary anchorage device (TAD)
from the occlusal surface of upper first molar and (B) insertion site (orange) for IZC TAD.
After ascertaining the insertion point and marking it with a dental probe, a self-drilling
mini-implant was placed at 90 degrees to the buccal cortical plate at that point;
after a couple of turns to the driver, an initial notch in the bone was created, after
which the bone screw driver direction changed by 55 to 70 degrees toward the tooth
crown (downward), which helps bypass the roots of the teeth and direct the screw into
the IZC area of the maxilla.[17] The mini-implant was screwed until only the head of the screw was visible outside
the alveolar mucosa ([Fig. 3]). Mini-implants were applied for the retraction and distalization mechanics of teeth
in the upper arch. The installed mini-implants were loaded with about 227 to 397 g
of force per side for an average of 6 months using an elastic power chain (Ormco,
Glendora, California, United States).[14]
[18]
Fig. 3 (A) Orientation of the infrazygomatic crest (IZC) temporary anchorage device (TAD) at
the start of the installation procedure 90 degrees to the buccal cortical plate. (B) Change the direction by 55 to 70 degrees after penetration of the buccal cortical
plate by approximately 1 mm. (C) Final position of IZC TAD after insertion.
Postoperative Care Instructions
The postoperative care instructions are as follows:
-
Gently brush the miniscrew and use of soft bristle toothbrush.
-
Do not touch miniscrew with the tongue or fingers.
-
Avoid eating hard food during the first 2 days of insertion.
-
Do not tap the miniscrew head with the toothbrush.
Data Management and Analysis
Data Management and Analysis
Data Collection
Postoperative Pain
The patients were asked to record any pain experienced on a visual analog scale (VAS)
score sheet at 24 hours and 1 week postplacement[19] (10 = severe pain and 0 = no pain).
Primary Stability
For each patient, the primary stability was measured immediately after insertion using
EasyCheck (on a scale from 1 to 99) (EasyCheck Genoss Co., Ltd, Jagok-ro, Gangnam-gu,
Seoul, Republic of Korea).
The attack pole was directly connected perpendicularly 90 degrees to the mini-implant
head as recommended by the manufacturer ([Fig. 4]).[20] Stability measurement was applied immediately after TAD insertion since primary
stability depends on the mechanical engagement of the mini-implant and bone, and it
does not require a period for osseointegration.[21]
Fig. 4 Stability measuring using EasyCheck device where the attack pole directed about 90 degrees
to the temporary anchorage device head.
Sinus Perforation
Immediately after surgery, a CBCT scan (3D eXam Plus; KaVo Dental, Biberach, Germany)
was performed to verify the implant position relative to the adjacent roots and maxillary
sinus to evaluate the incidence and degree of root proximity and sinus penetration/perforation,
respectively.[10] The OnDemand3D software was used to measure the incidence of penetration and the
distance between the distal tip of the mini-implant and the cortical plate of the
sinus floor by tracing its long axis. The value was labeled as positive if the mini-implant
penetrated the interior wall of the sinus[18] ([Fig. 5]).
Fig. 5 Typical reactions of the maxillary sinus membrane to different penetration depths:
(A) and (B) are the cone beam computed tomography images obtained immediately after insertion.
(A) There is no penetration while (B) penetration depth is about 3.8 mm.
Late Stability
The mini-implants' late stability was evaluated 2 months postinsertion using the same
device and method for measuring primary stability.
Failure Rate
Failure was defined as the mini-implant having to be removed due to looseness or peri-implant
inflammation or that it had fallen out after placement. Its stability was reassessed
regularly every 3 weeks over 6 months.[22]
Reliability
One calibrated investigator made all measurements. The sinus penetration and mini-implant
stability measurements were repeated at 2-week intervals in five randomly selected
patients (10 mini-implants). The intraclass correlation coefficient was used to assess
intraexaminer reliability for mini-implant stability (0.76), while the kappa test
was used to assess intraexaminer reliability for sinus penetration (0.79; [Table 1]). These findings are considered good and reliable for these measurement techniques;
therefore, some simple modifications could be made to the technique to increase accuracy.
Table 1
Results of reliability tests for penetration and mini-implant stability measurements
|
Reliability analysis
|
N
|
Value
|
Approximate significance
|
|
Stability reliability (ICC)
|
10
|
0.76
|
0.003
|
|
Sinus penetration reliability (kappa test) test
|
10
|
0.79
|
0.007
|
Abbreviation: ICC, intraclass correlation coefficient.
Data Analysis
The data were analyzed using the SPSS software (version 26.0; IBM Corp., Armonk, New
York, United States). Since pain perception, success rate, and sinus penetration were
nonparametric, they were reported using nonparametric descriptive statistics and compared
between groups using Wilcoxon's test. Since the stability measurements were scale
data, their normality was assessed using Shapiro–Wilk's test. Primary stability was
not normally distributed, so it was compared between groups using Wilcoxon's test.
Late stability was normally distributed, so it was compared between the groups using
a paired-t test.
Results
The mean primary stability measurement was significantly lower for the 12-mm (44.3)
than for the 14-mm (46.5) mini-implants (p < 0.05; [Table 2]). However, the mean late stability measurement did not differ significantly between
the 12-mm (36.5) and 14-mm (37.5) mini-implants (p > 0.05; [Table 3]).
Table 2
Descriptive and comparative statistics for the primary stability of the two mini-implant
lengths (12 mm/14 mm)
|
Length
|
N
|
Descriptive statistic
|
Comparative statistic
|
|
Minimum
|
Maximum
|
Mean
|
SD
|
WSR test
|
p-Value[a]
|
|
Primary stability
|
12 mm
|
24
|
37
|
60
|
44.3
|
5.5
|
−2.428
|
0.015
|
|
14 mm
|
24
|
39
|
56
|
46.5
|
5.7
|
Abbreviations: SD, standard deviation; WSR, Wilcoxon's signed rank.
a
p-Value < 0.05 is considered as significant.
Table 3
Descriptive and comparative statistics for the two lengths (12 mm/14 mm) mini-implant
late stability
|
Length
|
N
|
Descriptive statistic
|
Comparative statistic
|
|
Minimum
|
Maximum
|
Mean
|
SD
|
Pairedt-test
|
p-Value
|
|
Late stability
|
12 mm
|
24
|
30
|
44
|
36.5
|
3.7
|
−1.397
|
0.176
|
|
14 mm
|
24
|
30
|
47
|
37.5
|
4.5
|
Abbreviation: SD, standard deviation.
Note: p-Value < 0.05 is considered as significant.
Similarly, the sinus penetration rate did not differ significantly between the 12-mm
(54.2%) and 14-mm (62.5%) mini-implants (p > 0.05; [Table 4]). Moreover, the success rate did not differ significantly between the 12-mm (79.2%)
and 14-mm (83.3%) mini-implants (p > 0.05; [Table 5]).
Table 4
Maxillary sinus penetration descriptive and comparative statistics
|
Length
|
Sinus penetration
|
N
|
Descriptive statistic
|
Comparative statistics
|
|
Frequency
|
Percentage
|
WSR test
|
p-Value
|
|
12 mm
|
No penetration
|
24
|
11
|
45.8%
|
−0.816
|
0.414
|
|
Penetration
|
13
|
54.2%
|
|
14 mm
|
No penetration
|
24
|
9
|
37.5%
|
|
Penetration
|
15
|
62.5%
|
Abbreviation: WSR, Wilcoxon's signed rank.
Note: p-Value < 0.05 is considered as significant.
Table 5
Descriptive and comparative statistics for failure rate comparison between the two
lengths mini-implants (12 mm/14 mm)
|
Length
|
Status
|
N
|
Descriptive statistic
|
Comparative statistic
|
|
Frequency
|
Percentage
|
WSR test
|
p-Value
|
|
12 mm
|
Failure
|
24
|
5
|
20.8%
|
−0.447
|
0.655
|
|
Success
|
18
|
79.2%
|
|
14 mm
|
Failure
|
24
|
4
|
16.7%
|
|
Success
|
20
|
83.3%
|
Abbreviation: WSR, Wilcoxon's signed rank.
Note: p-Value < 0.05 is considered as significant.
Regarding pain perception, while most patients experienced pain on the first day,
it was greater with the 14 mm than with the 12-mm mini-implants ([Table 6]). For the 14-mm mini-implants, 16.7% were associated with severe pain and 4.2% with
unbearable pain. In contrast, for the 12-mm implants, most were associated with mild
to moderate pain, 12.5% with severe pain, and none with unbearable pain. After 1 week,
only 4.1% of the 12-mm and 12.5% of the 14-mm mini-implants were associated with mild
pain ([Table 7]).
Table 6
Descriptive and comparative statistics for patients' pain perception on the first-day
postinsertion
|
Length
|
Pain perception
|
N
|
Descriptive statistic
|
Comparative statistic
|
|
Frequency
|
Percentage
|
WSR test
|
p-Value
|
|
12 mm
|
No pain
|
24
|
1
|
4.2%
|
−0.816
|
0.415
|
|
Mild
|
10
|
41.7%
|
|
Moderate
|
10
|
41.7%
|
|
Severe
|
3
|
12.5%
|
|
Unbearable
|
0
|
0
|
|
14 mm
|
No pain
|
24
|
1
|
4.2%
|
|
Mild
|
9
|
37.5%
|
|
Moderate
|
9
|
37.5%
|
|
Severe
|
4
|
16.7%
|
|
Unbearable
|
1
|
4.2%
|
Abbreviation: WSR, Wilcoxon's signed rank.
Note: p-Value < 0.05 is considered as significant.
Table 7
Descriptive and comparative statistics for patients' pain first-week postinsertion
|
Length
|
Pain first week
|
N
|
Descriptive statistic
|
Comparative statistic
|
|
Frequency
|
Percentage
|
WSR test
|
p-Value
|
|
12 mm
|
No pain
|
24
|
23
|
95.8%
|
−1.414
|
0.157
|
|
Mild
|
1
|
4.1%
|
|
Moderate
|
0
|
0%
|
|
Severe
|
0
|
0%
|
|
Unbearable
|
0
|
0%
|
|
14 mm
|
No pain
|
24
|
21
|
87.5%
|
|
Mild
|
3
|
12.5%
|
|
Moderate
|
0
|
0%
|
|
Severe
|
0
|
0%
|
|
Unbearable
|
0
|
0%
|
Abbreviation: WSR, Wilcoxon's signed rank.
Note: p-Value < 0.05 is considered as significant.
Discussion
TAD Stability in the IZC
Mini-implant stability can be divided into primary (mechanical) and late stability.[23] Long-term dental implant success depends mainly on osseointegration.[24] Orthodontic mini-implant success primarily depends on mechanical stability, so any
signs of mini-implant loosening and lack of primary stability within the bone may
result in imminent failure of the orthodontic treatment; therefore, stability must
be checked early.[25]
[26] Since primary stability depends on the mechanical engagement between the mini-implant
and the bone, it does not require a period of osseointegration. Therefore, primary
stability was measured immediately after the insertion of the mini-implants into the
IZC area.[21] Many factors affect stability, including bone quantity and quality at the insertion
site and mini-implant design, such as length/diameter, thread form/size, pitch, material,
and insertion method.[27]
[28]
[29]
Previous studies have shown that mechanical engagement with surrounding bone is greater
with larger screws, producing greater stability.[30]
[31] Results of this study found that primary stability was significantly lower for 12-mm
mini-implants (mean = 44.3) than for 14-mm mini-implants (mean = 46.5; p = 0.015). Therefore, the longer mini-implants were more stable. However, while the
late stability measurements taken 2 months after mini-implant insertion showed decreased
stability for both lengths, the longer mini-implants were still more stable, although
the difference was nonsignificant (p = 0.176). This difference may be explained by the longer mini-implants having a greater
surface area of engagement with the bone, resulting in more bone contact and, thereby,
greater stability.[8]
Sinus Penetration
Hollow spaces around the nose, the maxillary sinuses are the first paranasal sinuses
to develop and the largest sinuses in the head. There are two maxillary sinuses in
the maxillary bones located in the cheek area next to the nose. They are lined with
a membrane called the Schneiderian membrane, which is attached to the interior wall
of the maxillary sinus. It is formed from a thin pseudociliated stratified respiratory
epithelium layer overlaid by the periosteum layer. It establishes an essential barrier
for the defense and protection of the sinus cavity. Its integrity is vital for normal
sinus function.[32] This study aimed to measure the incidence of sinus penetration by mini-implants,
which was labeled as positive if the mini-implant penetrated the interior wall of
the sinus.
Regarding the incidence of sinus penetration, Chang et al[10] found that 48.0% of TADs inserted into the IZC perforated the maxillary sinus with
a mean depth of 3.23 mm. Jia et al[18] reported a higher penetration incidence of 78.3%. This study showed that the penetration
rate was higher with 14-mm TADs (62.5%) than with 12-mm TADs (54.2%), although the
difference was nonsignificant.
Reiser et al reported that the sinus membrane became elevated when mini-implants penetrated
<2 mm into the maxillary sinus, which enhanced healing since it assists the formation
of a blood clot that provides a scaffold for the formation of bone in this region.
However, the Schneiderian membrane could be perforated if the mini-implant extends
>2 mm into the maxillary sinus, which may result in the discharge of bone fragments
inside the maxillary sinus, compromising its healing ability and increasing the risk
for sinusitis.[32]
Jia et al[18] stated that a penetration depth of <1 mm is recommended for IZC mini-implant anchorage
to enhance primary stability. In contrast, Chang et al[10] claimed that perforation by TADs may be unnecessary, with a mean of 3.23 mm resulting
in a 21.3% decrease in insertion torque.
Based on the previous studies, it can be concluded that it is better to avoid sinus
penetration, but if it happens, keeping it <2 mm may minimally affect the prognosis.
The finding of the present study showed that while the longer mini-implants had higher
sinus penetration rates and were more likely to go deeper into the sinus (> 2 mm),
increasing the risk for side effects such as sinusitis, however, the failure rate
of both mini-implants lengths (12 and 14 mm) did not differ significantly as described
later.
Failure Rate
Mini-implants can be considered successful if they are maintained inside the bone
until the treatment goals are achieved or their planned removal, whereas mini-implants
are considered to have failed if they have severe clinical mobility and cannot act
as a stable anchor, necessitating their replacement or removal.[22] Their loss within less than 6 months after placement, the minimal interval for anchorage
to retract the maxilla, is also considered a failure.[30]
[33] Many factors can lead to mini-implant failure, such as their loosening due to inflammation
around the insertion site, overloading, cortical bone thickness and mineral density,
screw design, and root proximity.[34]
[35]
[36]
In the present study, TAD was considered failed if it needed to be removed before
treatment goals were achieved due to mini-implant fracture, uncontrollable soft tissue
inflammation, severe mobility, and/or host factors (root damage) or if it had fallen
out after placement. The failure rate for the mini-implants was checked over 6 months.
Previous studies have reported differing success and failure rates for mini-implants
inserted into the IZC region. Jia et al[18] reported an overall success rate of 96.7% for mini-implants inserted into the IZC
area. Similarly, Chang et al[14] reported an overall success rate of 93.7% for mini-implants, which is considered
clinically high and very optimistic. However, Gill et al[13] reported a failure rate of 28.1%. Similarly, Uribe et al[22] reported a failure rate of 21.8% for mini-implants placed in the IZC, which seems
lower than those in the other studies.
The result of this study elicited success rates of 79.2% for the 12-mm mini-implants
and 83.3% for the 14-mm mini-implants, although the difference was nonsignificant
(p = 1.000). Although lower than those of Jia et al and Chang et al, these values of
success rates are still within an acceptable range and clinically applicable. The
differences in success/failure rates between the present study and the previous studies
could be related to several factors, such as the study design, study sample, patient
characteristics, and the specific criteria used to define success or failure.
Factors such as sex, age, mini-implant length (12/14 mm), occlusogingival position,
force application method, and insertion angle may not be significantly related to
lower or higher odds of mini-implant failure.[13]
[37] Nonetheless, the present finding may agree with Gill et al,[13] who found no significant difference in failure rate between these two mini-implant
sizes.[13]
Although failure rates do not appear to differ significantly for both longer and shorter
mini-implants, the longer mini-implants undoubtedly may still have disadvantages regarding
possible side effects. Indeed, they are more likely to damage adjacent structures.
Therefore, a shorter mini-implant should be preferred over longer mini-implants whenever
possible.
Pain Perception
Sarul et al[31] used two mini-implant sizes in the BS area, showing that smaller mini-implants were
significantly better tolerated by patients than the larger mini-implants. Kuroda et
al[38] reported that about 60% of patients given larger mini-implants experienced pain
on the third-day postinsertion.
The current study assessed pain perception using a VAS, showing that while most patients
still experienced pain on the first day, it was more severe on the side treated with
the longer mini-implants. Moreover, while pain had noticeably reduced after 1 week,
some patients still felt mild pain or discomfort, which was reported for 4.1% of the
12-mm mini-implants versus 12.5% for the 14-mm mini-implants.
These findings agree with Sarul et al and Kuroda et al, who reported that longer mini-implants
produced more discomfort, which was clinically important but not significantly different.
One possible cause of the difference in pain perception could be the difference in
length, with longer mini-implants going deeper into the sinus and having a higher
likelihood of damaging the Schneiderian membrane, potentially resulting in the discharge
of bone fragments inside the maxillary sinus, compromising its ability to heal and
increasing the risk for sinusitis.[32] However, the major concern for postoperative pain is individual-specific and subjective.
Conclusion
-
There could be a correlation between mini-implant length and sinus penetration.
-
The mini-implant length may have an association with pain perception at the first-week
postinsertion.
-
There could be no significant correlation and the mini-implant length and failure
rate.
-
Shorter mini-implant may be as efficient as a larger one and could be safer.